These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 34375725)

  • 1. Multifunctional plant virus nanoparticles in the next generation of cancer immunotherapies.
    Shahgolzari M; Dianat-Moghadam H; Fiering S
    Semin Cancer Biol; 2022 Nov; 86(Pt 2):1076-1085. PubMed ID: 34375725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging Potential of Plant Virus Nanoparticles (PVNPs) in Anticancer Immunotherapies.
    Shahgolzari M; Fiering S
    J Cancer Immunol (Wilmington); 2022; 4(1):22-29. PubMed ID: 35600219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plant Virus Nanoparticles for Vaccine Applications.
    Santoni M; Zampieri R; Avesani L
    Curr Protein Pept Sci; 2020; 21(4):344-356. PubMed ID: 32048964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentiating Cancer Immunotherapy Using Papaya Mosaic Virus-Derived Nanoparticles.
    Lebel MÈ; Chartrand K; Tarrab E; Savard P; Leclerc D; Lamarre A
    Nano Lett; 2016 Mar; 16(3):1826-32. PubMed ID: 26891174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gold nanoparticle mediated cancer immunotherapy.
    Almeida JP; Figueroa ER; Drezek RA
    Nanomedicine; 2014 Apr; 10(3):503-14. PubMed ID: 24103304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plant Viral Nanoparticle Conjugated with Anti-PD-1 Peptide for Ovarian Cancer Immunotherapy.
    Gautam A; Beiss V; Wang C; Wang L; Steinmetz NF
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesoporous Silica as a Versatile Platform for Cancer Immunotherapy.
    Nguyen TL; Choi Y; Kim J
    Adv Mater; 2019 Aug; 31(34):e1803953. PubMed ID: 30417454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanovaccines for cancer immunotherapy: Focusing on complex formation between adjuvant and antigen.
    Hashemi Goradel N; Nemati M; Bakhshandeh A; Arashkia A; Negahdari B
    Int Immunopharmacol; 2023 Apr; 117():109887. PubMed ID: 36841155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant helical plant virus-based nanoparticles for vaccination and immunotherapy.
    Narayanan KB; Han SS
    Virus Genes; 2018 Oct; 54(5):623-637. PubMed ID: 30008053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-delivery of immunomodulators in biodegradable nanoparticles improves therapeutic efficacy of cancer vaccines.
    Da Silva CG; Camps MGM; Li TMWY; Chan AB; Ossendorp F; Cruz LJ
    Biomaterials; 2019 Nov; 220():119417. PubMed ID: 31419588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The quest for nanoparticle-powered vaccines in cancer immunotherapy.
    Sun Z; Zhao H; Ma L; Shi Y; Ji M; Sun X; Ma D; Zhou W; Huang T; Zhang D
    J Nanobiotechnology; 2024 Feb; 22(1):61. PubMed ID: 38355548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plant Virus Nanoparticles Combat Cancer.
    Shahgolzari M; Venkataraman S; Osano A; Akpa PA; Hefferon K
    Vaccines (Basel); 2023 Jul; 11(8):. PubMed ID: 37631846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA Nanotechnology-Mediated Cancer Immunotherapy.
    Lin YX; Wang Y; Blake S; Yu M; Mei L; Wang H; Shi J
    Theranostics; 2020; 10(1):281-299. PubMed ID: 31903120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of Plant Virus Nanoparticle-Based in Situ Vaccination with Chemotherapy Potentiates Antitumor Response.
    Lee KL; Murray AA; Le DHT; Sheen MR; Shukla S; Commandeur U; Fiering S; Steinmetz NF
    Nano Lett; 2017 Jul; 17(7):4019-4028. PubMed ID: 28650644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combinatory therapy adopting nanoparticle-based cancer vaccination with immune checkpoint blockade for treatment of post-surgical tumor recurrences.
    Chung CK; Da Silva CG; Kralisch D; Chan A; Ossendorp F; Cruz LJ
    J Control Release; 2018 Sep; 285():56-66. PubMed ID: 30008371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic Vaccines for Cancer Immunotherapy.
    Wang J; Mamuti M; Wang H
    ACS Biomater Sci Eng; 2020 Nov; 6(11):6036-6052. PubMed ID: 33449675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoscale Metal-Organic Frameworks for Cancer Immunotherapy.
    Ni K; Luo T; Nash GT; Lin W
    Acc Chem Res; 2020 Sep; 53(9):1739-1748. PubMed ID: 32808760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multifunctional nanoparticles for cancer immunotherapy.
    Saleh T; Shojaosadati SA
    Hum Vaccin Immunother; 2016 Jul; 12(7):1863-75. PubMed ID: 26901287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delivery strategies of cancer immunotherapy: recent advances and future perspectives.
    Zhao Z; Zheng L; Chen W; Weng W; Song J; Ji J
    J Hematol Oncol; 2019 Nov; 12(1):126. PubMed ID: 31779642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymeric nanoparticle-based nanovaccines for cancer immunotherapy.
    Zhang Y; Chen J; Shi L; Ma F
    Mater Horiz; 2023 Feb; 10(2):361-392. PubMed ID: 36541078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.